← Back to Search

Local Anesthetic

Single-injection bupivacaine HCl plus liposomal bupivacaine for Shoulder Pain

N/A
Waitlist Available
Led By Anthony T Machi, MD
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours
Awards & highlights

Study Summary

This trial will compare two methods of pain relief for shoulder surgery patients - one with a single injection of bupivacaine HCl followed by a bupivacaine CISB, and the other with a single injection of bupivacaine HCl plus liposomal bupivacaine. Patients will be surveyed for pain control and other outcomes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 72 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Median pain score on POD1
Secondary outcome measures
Cumulative Area under Curve median pain score on POD1-3

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Liposomal Bupivacaine Added to Interscalene BlockExperimental Treatment1 Intervention
23 patients will be enrolled to receive a single-injection bupivacaine HCl interscalene block with liposomal bupivacaine added to same injection.
Group II: Bupivacaine HCl/Bupivacaine CISBActive Control1 Intervention
23 patients will be enrolled to receive a single-injection bupivacaine HCL interscalene block with bupivacaine CISB added.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Single-injection bupivacaine HCl plus liposomal bupivacaine
2019
N/A
~50

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
1,047 Previous Clinical Trials
1,053,751 Total Patients Enrolled
4 Trials studying Shoulder Pain
330 Patients Enrolled for Shoulder Pain
Anthony T Machi, MDPrincipal InvestigatorUT Southwestern Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots for prospective participants in this research endeavor?

"As can be seen on clinicaltrials.gov, this specific medical trial is no longer recruiting patients with the last update being posted on July 1st 2022. Despite that fact, there are still 71 other trials currently seeking enrolment from volunteers."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Interscalene Bupivacaine With Either Liposomal Bupivacaine or Continuous Peripheral Nerve Block for Shoulder Arthroscopy
Anthony Machi 2019. "Interscalene Bupivacaine With Either Liposomal Bupivacaine or Continuous Peripheral Nerve Block for Shoulder Arthroscopy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03816982.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top